Camptothecin: current perspectives

CJ Thomas, NJ Rahier, SM Hecht - Bioorganic & medicinal chemistry, 2004 - Elsevier
This review provides a detailed discussion of recent advances in the medicinal chemistry of
camptothecin, a potent antitumor antibiotic. Two camptothecin analogues are presently …

The triple helix: 50 years later, the outcome

M Duca, P Vekhoff, K Oussedik, L Halby… - Nucleic acids …, 2008 - academic.oup.com
Triplex-forming oligonucleotides constitute an interesting DNA sequence-specific tool that
can be used to target cleaving or cross-linking agents, transcription factors or nucleases to a …

Triple helix formation and the antigene strategy for sequence-specific control of gene expression

D Praseuth, AL Guieysse, C Helene - Biochimica et Biophysica Acta (BBA) …, 1999 - Elsevier
Specific gene expression involves the binding of natural ligands to the DNA base pairs.
Among the compounds rationally designed for artificial regulation of gene expression …

Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs

C Bailly - Critical reviews in oncology/hematology, 2003 - Elsevier
Homocamptothecins (hCPTs) represent a new generation of antitumor agents targeting DNA
topoisomerase I. The expanded seven-membered lactone E-ring that characterizes hCPTs …

Triplex formation by oligonucleotides containing 5-(1-propynyl)-2 '-deoxyuridine: Decreased magnesium dependence and improved intracellular gene targeting

L Lacroix, J Lacoste, JF Reddoch, JL Mergny… - Biochemistry, 1999 - ACS Publications
Oligonucleotides capable of sequence-specific triple helix formation have been proposed as
DNA binding ligands useful for modulation of gene expression and for directed genome …

Exploring the cellular activity of camptothecin-triple-helix-forming oligonucleotide conjugates

PB Arimondo, CJ Thomas, K Oussedik… - … and cellular biology, 2006 - Taylor & Francis
Topoisomerase I is a ubiquitous DNA-cleaving enzyme and an important therapeutic target
in cancer chemotherapy for camptothecins (CPTs). These drugs stimulate DNA cleavage by …

Triplex‐forming molecules: from concepts to applications

M Faria, C Giovannangeli - The Journal of Gene Medicine: A …, 2001 - Wiley Online Library
The ability to specifically manipulate gene expression has wide‐ranging applications in
experimental biology and in gene‐based therapeutics. The design of molecules that …

Oligonucleotides and oligonucleotide conjugates: a new approach for cancer treatment

TD Ros, G Spalluto, M Prato… - Current medicinal …, 2005 - ingentaconnect.com
In this account we summarise recent studies on oligonucleotides and oligonucleotide
derivatives and their utilisation in antigene, antisense and decoy approaches, with particular …

[HTML][HTML] Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I

PB Arimondo, A Boutorine, B Baldeyrou, C Bailly… - Journal of Biological …, 2002 - ASBMB
To achieve a sequence-specific DNA cleavage by topoisomerase I, derivatives of the
antitumor drug camptothecin have been covalently linked to triple helix-forming …

Sequence-specific trapping of topoisomerase I by DNA binding polyamide− camptothecin conjugates

CCC Wang, PB Dervan - Journal of the American Chemical …, 2001 - ACS Publications
Hairpin pyrrole− imidazole polyamides are synthetic ligands that bind in the minor groove of
DNA with affinities and specificities comparable to those of DNA binding proteins. Three …